Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History INBX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics INBX

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Inhibrx Biosciences, Inc.

INBX
Current price
20.92 USD +0.87 USD (+4.34%)
Last closed 18.35 USD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 220 178 432 USD
Yield for 12 month +61.30 %
1Y
3Y
5Y
10Y
15Y
INBX
21.11.2021 - 28.11.2021

Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates include INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 to treat unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck squamous cell carcinoma, gastric or gastroesophageal junction adenocarcinoma, renal cell carcinoma, and urothelial cell carcinoma. Inhibrx Biosciences, Inc. was incorporated in 2024 and is based in La Jolla, California. Address: 11025 North Torrey Pines Road, La Jolla, CA, United States, 92037

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.00 USD

P/E Ratio

0.13

Dividend Yield

Financials INBX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures INBX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+200 000 USD

Last Year

+1 800 000 USD

Current Quarter

Last Quarter

+100 000 USD

Current Year

-2 085 000 USD

Last Year

+609 000 USD

Current Quarter

Last Quarter

-589 000 USD
EBITDA -229 863 008 USD
Operating Margin TTM -116 231.50 %
Price to Earnings 0.13
Return On Assets TTM -107.28 %
PEG Ratio
Return On Equity TTM 41.18 %
Wall Street Target Price 12.00 USD
Revenue TTM 200 000 USD
Book Value 6.52 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM -200 607 008 USD
Earnings per share 119.02 USD
Diluted Eps TTM 119.02 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin 861 485.50 %

Stock Valuation INBX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 0.13
Forward PE
Enterprise Value Revenue 550.94
Price Sales TTM 1 100.89
Enterprise Value EBITDA 0.064
Price Book MRQ 2.33

Technical Indicators INBX

For 52 Weeks

10.80 USD 17.79 USD
50 Day MA 12.64 USD
Shares Short Prior Month 706 979
200 Day MA 14.11 USD
Short Ratio 6.96
Shares Short 782 491
Short Percent 6.73 %